Status:
COMPLETED
Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Liver Disease
Eligibility:
All Genders
18-100 years
Brief Summary
Background: In a liver biopsy, a small piece of liver is removed. A percutaneous liver biopsy (PLB) is done through a needle on the right side of your belly. In a transjugular liver biopsy (TLB), the ...
Detailed Description
Millions of Americans are diagnosed with some form of Hepatitis or other liver disease requiring treatment. Liver biopsies are frequently performed mainly to stage disease, aid in diagnosis and to gui...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Criteria for subject selection will include the following:
- 18 years of age or older
- able to read, write and speak English.
- capable of providing informed consent
- subjects undergoing an elective PLB or TLB.
- baseline pain level will be assessed prior to the liver biopsy using both VAS and NPS.
- an assessment of pain threshold using a medical device called a dolorimeter.
- must be enrolled into the 91-DK-0214 protocol
- EXCLUSION CRITERIA:
- patients who are unable to give consent will be excluded from the study.
- Patient report of a pain level of four or more pre liver biopsy
- The patient must undergo a baseline pain assessment prior to the liver biopsy using the dolorimeter.
Exclusion
Key Trial Info
Start Date :
November 20 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 21 2016
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT02311348
Start Date
November 20 2014
End Date
December 21 2016
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892